The Manufacturers Life Insurance Company Has $79.07 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

The Manufacturers Life Insurance Company grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 860,126 shares of the medical device company's stock after buying an additional 5,271 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.43% of Cooper Companies worth $79,071,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the fourth quarter valued at $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter valued at about $34,000. New Age Alpha Advisors LLC acquired a new stake in Cooper Companies in the 4th quarter valued at about $38,000. Covestor Ltd grew its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the period. Finally, West Financial Advisors LLC bought a new position in Cooper Companies during the fourth quarter worth about $49,000. 24.39% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently issued reports on COO. BNP Paribas raised Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Price Performance

Shares of NASDAQ COO traded up $1.16 during trading hours on Friday, hitting $82.30. 1,708,555 shares of the stock were exchanged, compared to its average volume of 1,430,222. The company's fifty day simple moving average is $81.44 and its two-hundred day simple moving average is $91.91. The company has a market cap of $16.46 billion, a PE ratio of 42.21, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.